Nuclear receptors: recent drug discovery for cancer therapies

L Zhao, S Zhou, JÅ Gustafsson - Endocrine reviews, 2019 - academic.oup.com
Nuclear receptors (NRs) are transcription factors actively involved in many aspects of human
physiology and pathology, serving as sensors of stimuli, master regulators of downstream …

Treatment and trials in non-metastatic castration-resistant prostate cancer

SD Lokeshwar, Z Klaassen, F Saad - Nature Reviews Urology, 2021 - nature.com
Metastatic prostate cancer is associated with considerable morbidity and mortality. Standard
treatment for non-metastatic prostate cancer, to prevent metastatic progression, is androgen …

[HTML][HTML] European cancer mortality predictions for the year 2020 with a focus on prostate cancer

G Carioli, P Bertuccio, P Boffetta, F Levi, C La Vecchia… - Annals of …, 2020 - Elsevier
Background Current cancer mortality figures are important for disease management and
resource allocation. We estimated mortality counts and rates for 2020 in the European Union …

Application of artificial intelligence in pharmaceutical and biomedical studies

A Thakur, AP Mishra, B Panda… - Current …, 2020 - ingentaconnect.com
Background: Artificial intelligence (AI) is the way to model human intelligence to accomplish
certain tasks without much intervention of human beings. The term AI was first used in 1956 …

Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data

L Ye, DK Ngan, T Xu, Z Liu, J Zhao, S Sakamuru… - Toxicology and applied …, 2022 - Elsevier
Drug-induced liver injury (DILI) and cardiotoxicity (DICT) are major adverse effects triggered
by many clinically important drugs. To provide an alternative to in vivo toxicity testing, the US …

[HTML][HTML] Nuclear estrogen receptors in prostate cancer: from genes to function

S Belluti, C Imbriano, L Casarini - Cancers, 2023 - mdpi.com
Simple Summary Estrogens are steroid hormones that interact with nuclear receptors (ERα
and ERβ) and a membrane G-protein-coupled receptor (GPER) to regulate multiple …

Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer

J Li, N Liu, H Zhou, P Xian, Y Song, X Tang, Y Li… - British Journal of …, 2023 - nature.com
Background Castration-resistant prostate cancer (CRPC) is refractory to hormone treatment.
This study aims to explore the effect and underlying mechanisms of immunoproteasome …

Discovery and characterization of benzimidazole derivative XY123 as a potent, selective, and orally available RORγ inverse agonist

X Wu, H Shen, Y Zhang, C Wang, Q Li… - Journal of Medicinal …, 2021 - ACS Publications
Receptor-related orphan receptor γ (RORγ) has emerged as an attractive therapeutic target
for the treatment of cancer and inflammatory diseases. Herein, we report our effort on the …

[HTML][HTML] Peptide-conjugated nano delivery systems for therapy and diagnosis of cancer

I Gaurav, X Wang, A Thakur, A Iyaswamy, S Thakur… - Pharmaceutics, 2021 - mdpi.com
Peptides are strings of approximately 2–50 amino acids, which have gained huge attention
for theranostic applications in cancer research due to their various advantages including …

[HTML][HTML] Making the case for autophagy inhibition as a therapeutic strategy in combination with androgen-targeted therapies in prostate cancer

AM Elshazly, DA Gewirtz - Cancers, 2023 - mdpi.com
Simple Summary This paper is one in a series of articles that investigate the functional forms
of autophagy induced in tumor cells in response to various chemotherapeutic modalities …